Skip to main content
. 2011 Nov;18(11):1943–1950. doi: 10.1128/CVI.05122-11

Fig. 3.

Fig. 3.

HBsAg levels according to disease stage. (a) Data from Hannover cohort. (b) Data from Pisa cohort. CHB patients in the low-replicative phase in the Hannover cohort have higher HBsAg levels than inactive carriers without liver disease in the Pisa cohort; chronic active hepatitis and cirrhotic patients in the Pisa cohort are comparable to those HBeAg-negative patients classified as immune clearance phase in the Hannover cohort.